Multiple sclerosis (MS) is a neurological disorder that causes paralysis in young adults and affects women more frequently than men. The etiology of MS is not known, but it is generally viewed as an autoimmune disease of the central nervous system (CNS), influenced by genetic and environmental factors. Recent studies have identified interleukin-7 receptor a (IL-7Ra) as a risk factor for MS. But the role of IL-7Ra in experimental autoimmune encephalomyelitis (EAE) model of MS is not known.
Introduction
Multiple sclerosis (MS) is a neurological disorder that affects more than one million people worldwide. The disease usually begins in young adults and affects women more frequently than men.
1,2 About 30% of MS patients develop clinical paralysis and become wheel chair-bound for the rest of their lives, causing immense health and socioeconomic problems. In most patients MS begins as relapsing-remitting disease and over time it progresses to chronic progressive disease. Although relapsing MS is characterized by acute focal sclerotic lesions with myelin loss and infiltration of inflammatory cells in the central nervous system (CNS), axonal degeneration and brain atrophy contribute to irreversible long-term disability in chronic progressive MS. 2, 3 Although the etiology of MS is not known, it is generally viewed as a myelin antigen (Ag)-reactive T-helper (Th) 1 and Th17 cell-mediated autoimmune disease influenced by genetic and environmental factors. 4 Thus, many of the current treatments used to inhibit the clinical symptoms of MS target the immune and inflammatory responses of the brain.
Although the human leukocyte antigen has long been considered a susceptibility gene for autoimmune diseases, recent studies have identified mutations in the interleukin-7 receptor a (IL-7Ra) chain as additional risk factors for MS. [5] [6] [7] [8] [9] [10] [11] Genomic convergence analyses identified a nonsynonymous coding single-nucleotide polymorphism in IL-7Ra (rs6897932; T244I) that affects alternative splicing and subsequent skipping of exon 6. 5, 6 This may increase the ratio of soluble to membranebound IL-7R for individuals with this polymorphism. 6 A similar analysis reported that MS patients have a significant increase of IL-7 and IL-7R in the cerebrospinal fluid compared with patients with other neurological diseases. 7, 8 It is interesting that the IL-7Ra is downregulated in human CD4 þ CD25 þ regulatory T cells (Tregs) that have suppressive activity on effector T cells in MS and other autoimmune diseases. 12, 13 IL-7 is a cytokine produced by stromal epithelial cells in the thymus that signals through IL-7R complex to promote B-and T-cell development and rescues thymocytes from apoptotic cell death. 14, 15 The IL-7R is comprised of the common g chain (gc; CD132) and the IL-7R a chain (IL-7Ra, CD127). The gc is shared by receptors for the cytokines IL-2, IL-4, IL-9, IL-15 and IL-21 and mutation causes severe combined immunodeficiency in humans and mice. 16, 17 IL-7Ra-deficient (IL-7Ra
) mice have reduced number of thymic precursors with decreased survival and response to T-cell receptor-dependent and independent stimuli. 14, 18 Thymic stromal lymphopoietin is another cytokine that signals through IL7Ra/thymic stromal lymphopoietin receptor complex and stimulates the activation and differentiation of B cells, peripheral CD4
þ T cells and thymic myeloid dendritic cells.
its significance to pathogenesis of CNS inflammation and demyelination is not known. In this study we examined the impact of IL-7Ra deficiency on the development of experimental autoimmune encephalomyelitis (EAE) model of MS. We found that the IL-7Ra À/À male mice remained resistant to EAE in association with reduced neural Ag-induced Th1/Th17 responses, suggesting a role for IL-7Ra in conferring susceptibility to MS.
Results

IL-7Ra is essential for the development of EAE model of MS
To elucidate the role of IL-7Ra in the pathogenesis of MS, we first studied the development of EAE in IL-7Ra À/À female mice tested, two developed EAE with clinical scores as high as the WT female mice, whereas the remaining 10 mice developed no detectable clinical signs of EAE throughout the period of study (Table 1 ). These results demonstrate that IL-7Ra À/À female mice are less likely to develop EAE when compared with WT mice, whereas the IL-7Ra À/À male mice remained completely resistant to EAE. However, a one-way analysis of variance using the Bonferronni's multiple comparison test revealed no statistically significant gender difference in the clinical outcome of EAE. Thus our findings suggest that IL-7Ra confers susceptibility to EAE model of MS.
We then examined whether the attenuation of paralytic symptoms in the IL-7Ra À/À mice was associated with decreased inflammation and demyelination in the CNS. WT female mice immunized with MOGp35-55 showed 84% of the spinal cord quadrants positive for lesions with infiltration of mononuclear cells and extensive myelin loss on day 30 ( Figure 2 ). It is interesting that the IL-7Ra À/À female mice showed only 9% of spinal cord quadrants positive for lesions with infiltrating cells and myelin loss (nine-fold decrease, Po0.001) on day 30. Similarly, the WT male mice immunized with MOGp35-55 showed 88% and 89% of spinal cord quadrants positive for lesions with infiltrating mononuclear cells Figure 1 Development of EAE in IL-7Ra-deficient mice. Around 4-to-6-week-old wild-type (WT) female (') (n ¼ 12), IL-7Ra À/À female (K) (n ¼ 12), WT male (') (n ¼ 9) and IL-7Ra À/À male (K) (n ¼ 9), mice were induced to develop EAE by immunization with MOGp35-55 Ag. The clinical symptoms were scored every day in a blinded manner and presented as mean±s.e.m. for each group. The data represent four combined experiments. Figure 4) . Stimulation of spleen cells from WT mice with 1 and 2.5 mg ml À1 ConA resulted in the proliferation of 58 and 81% CD4 þ T cells, respectively. Whereas, the spleen cells from IL-7Ra
À/À mice with 1 and 2.5 mg ml À1 ConA caused the proliferation of only 35 and 45% of CD4 þ cells, respectively. Similarly, T-cell receptor activation using anti-CD3 Ab resulted in the proliferation of 89% of CD4 þ cells in WT mice compared with only 62% proliferating CD4 þ T cells in IL-7Ra À/À mice. These results suggest that the attenuation of EAE in IL-7Ra À/À mice was not contributed solely through changes in neural antigen-specific CD4 þ T-cell proliferation but by defective cellularity and associated autoimmune responses.
IL-7Ra
À/À mice induced to develop EAE express altered levels of inflammatory cytokines in the CNS To define the mechanism for attenuated EAE in the IL-7Ra
À/À mice, we examined the mRNA expression of Th1 and Th17 cell-derived inflammatory cytokines in the CNS of WT and IL-7Ra À/À mice on day 14 following induction of EAE ( Figure 4 ). The levels of interferon-g (IFNg) and IL-17 mRNA were significantly reduced in IL-7Ra À/À male and female mice when compared with WT mice. It is interesting that the level of the Th1 transcription factor T-bet was reduced in male IL-7Ra À/À mice, whereas T-bet was significantly increased in female IL-7Ra À/À mice, compared with WT. The levels of IFNg and IL-17 in the brain correlate with disease severity. The anti-inflammatory cytokines IL-4 and IL-10 were undetectable in all groups (data not shown).
To further define the mechanism for reduced EAE in the IL-7Ra À/À mice we examined the mRNA expression of the IL-12 family cytokines in the CNS of WT and IL-7Ra À/À mice ( Figure 5 ). It is interesting that several inflammatory cytokines were differentially regulated between the male and female IL-7Ra À/À mice when compared with their respective WT controls. Relative quantities of IL-27p28 and IL-12p35 were decreased in the IL-7Ra À/À male mice, whereas these cytokines were unchanged in the IL-7Ra À/À female mice. In addition, IL-23p19 was increased in the IL-7Ra À/À male mice, but unchanged in the females, and IL-12p40 was undetectable in the IL-7Ra À/À female mice, but unchanged in the males. These results suggest that the altered expression of IL-12 family cytokine could be another mechanism by which IL-7Ra À/À mice developed defective Th1/Th17 responses and remained resistant to EAE.
IL-7Ra is essential for IFNg and IL-17 production in EAE model of MS
To further determine the mechanisms in the attenuation of EAE in IL-7Ra À/À mice, we examined neural Aginduced Th1 and Th17 responses in IL-7Ra À/À mice ( Figure 6 ). Spleen cells from WT female mice sensitized with MOGp35-55 displayed a dose-dependent increase À/À male mice also showed significant decrease in the secretion of IFNg (Po0.001) and IL-17 (Po0.001) in response to Ag. However, both the IL-7Ra À/À female and male mice showed a decrease in the percentage of CD4 þ cells when compared with WT controls. This is consistent with previously published reports of decreased CD4 þ splenocyte cellularity in naive IL-7Ra À/À mice. 14, 22 It is possible that the observed decrease in cytokine secretion in the IL-7Ra À/À mice is due to a smaller proportion of CD4 þ cells and not directly related to alterations in cytokine secretion. To examine this we performed intracellular cytokine staining on the CD4 þ T-cell population to determine whether the decrease in cytokine secretion was a result of decreased Th1 and Th17 differentiation or simply a consequence of reduced CD4 þ splenocyte cellularity. (Figures 7a-c) . Therefore, the secretion of inflammatory cytokines is reduced in IL-7Ra À/À mice as a result of fewer CD4
þ /IL-17 þ and CD4 þ /IFNg þ splenocytes and deficient Th1 cell differentiation.
IL-7Ra is a critical regulator of IL-4 and IL-10 production in EAE model of MS As splenocytes from IL-7Ra À/À mice produce less IL-17 and IFNg we questioned whether the anti-inflammatory cytokines were modulated as well. Thus, we examined neural Ag-induced IL-4 and IL-10 secretion in whole spleen cultures ( Figure 6 , lower panels). Spleen cells from IL-7Ra À/À female mice sensitized with 10 mg ml 
IL-7Ra modulates the expansion of regulatory T cells in EAE model of MS
We then examined whether the attenuation of Th1/Th17 response and increase in IL-4 and IL-10 secretion in EAE was associated with increased Treg activity in IL-7Ra 
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Discussion
EAE is an autoimmune disease model of MS that has been used to study the mechanism of MS pathogenesis and to test the efficacy of potential therapeutic agents for the treatment of MS. [23] [24] [25] [26] The pathogenesis of EAE involves activation of immune cells, differentiation of neural Ag-induced Th1 and Th17 cells and secretion of myelinotoxic inflammatory cytokines in the CNS. In this study we have used the EAE model to determine the physiological role of IL-7R in the regulation of MS. We have demonstrated that the IL-7Ra À/À female mice were less likely to develop EAE compared with WT controls, whereas the IL-7Ra À/À male mice remained completely resistant to EAE. Of the 12 IL-7Ra
À/À female mice tested, only two developed EAE with clinical scores as high as the WT female mice, whereas the remaining 10 mice developed no detectable clinical signs of EAE throughout the period of study (Table 1) . However, a one-way analysis of variance using the Bonferronni's multiple comparison test revealed no statistically significant differences in mean maximum clinical score, average mean clinical score and MCS day 30 between the male and female IL-7Ra knockout and WT groups. Thus, our findings suggest the influence of IL-7Ra in mediating susceptibility to EAE. Epidemiological studies have suggested the existence of gender differences in the incidence of MS among patient populations. Although women are more likely to develop the disease (2:1), men progress faster from relapsing-remitting to secondary progressive MS and develop severe disease. 27, 28 Both female and male IL-7Ra À/À mice showed significantly reduced splenocyte proliferation in response to neural Ag compared with the WT mice (Figure 3a) . Although neural antigen-specific CD4 þ T-cell proliferation was similar in WT and IL-7Ra À/À mice (Figure 3b , Supplementary Figure 3 ), reduced cellularity and other associated autoimmune responses could be the mechanisms by which IL-7Ra regulates gender differences and susceptibility to EAE and MS.
It has been well recognized that differentiation of Th1 and Th17 cells and the secretion of IFNg and IL-17, respectively, associates with the development of EAE. 29 In this study we found that the spleen cells from (Figure 7) , suggesting that deficient Th1 differentiation may also contribute to the decreased clinical and pathological signs of EAE in IL-7Ra À/À mice. Earlier studies have shown that adoptive transfer of encephalitogenic T cells cultured in the presence of rIL-7 resulted in severe and prolonged EAE compared with the control and in vitro treatment with IL-7 resulted in increased IFNg secretion and Ag-specific T-cell proliferation. 30 Our findings are consistent with earlier reports showing upregulation of IFNg and IL-17 production by IL-7 in a model of rheumatoid arthritis. 31, 32 In addition, IFNg and IL-17 mRNA levels in the brains of IL-7Ra À/À mice were significantly reduced compared with WT controls. This decrease was accompanied by diminished T-bet expression in the IL-7Ra À/À male mice. The lower levels of secreted IFNg and IL-17 from Ag-stimulated spleen cells and reduced mRNA levels in the brain suggest that the À/À mice. Targeted disruption of IL-12p40, but not IL12p35 causes resistance to EAE indicating that the p40 subunit shared by IL-12 and IL-23 is critical for disease pathogenesis. 33, 34 It is interesting that the male IL-7Ra À/À mice had decreased levels of IL-12p35 and IL-27p28 brain mRNA, whereas female IL-7Ra À/À mice did not. IL-27 synergistically enhances the IL-12-induced production of IFNg and has been shown to be upregulated in the CNS and lymph nodes of mice throughout the course of EAE. 35, 36 The altered expression of IL-12p35, IL-12p40, IL-23p19 and IL-27p28 mRNA in the brain at the onset of EAE could be a mechanism by which IL-7Ra À/À mice develop resistance to EAE.
IL-4 and IL-10 are protective anti-inflammatory cytokines that regulate EAE and MS. [37] [38] [39] [40] We found that IL-4 and IL-10 secretion from whole-spleen culture was increased in IL-7Ra À/À mice. Despite fewer CD4 þ T cells, the IL-7Ra À/À mice secrete elevated levels of IL-4, suggesting an increase in neural antigen-induced Th2 differentiation. However, the contribution of other cell types, such as mast cells cannot be excluded. The increased secretion of IL-4 occurs concurrently with a decrease in IFNg secretion ( Figure 6 ). IFNg has been shown to induce apoptosis in developing mast cells. [42] [43] [44] In addition, IL-10 has been shown to maintain Foxp3 expression and Treg activity in the presence of colitis-induced inflammation. 45 Future studies will determine whether blocking IL-10 directly alters CD4 þ CD25 þ T-cell production or Foxp3 expression in the IL-7Ra À/À mice. Earlier studies have shown that IL-7Ra is downregulated in human Tregs and is a marker for identifying and purifying Treg populations. 12 In this study we found that IL-7Ra À/À mice induced to develop EAE show an increased proportion of Treg cells ( Figure 8 ; Table 2 ). Foxp3 is a transcription factor that serves as a marker for Treg cells. [46] [47] [48] [49] Defects in the Foxp3 gene expression disrupt the development of naturally occurring Tregs leading to fatal autoimmune and inflammatory diseases. 50 The role played by IL-7Ra in Foxp3 expression is somewhat controversial. In one study the percentage of CD4 þ Foxp3 þ splenocytes was reduced in the IL-7Ra À/À naive mice compared with controls. 51 In contrast, Bayer and colleagues reported that the percentage of CD4 þ Foxp3 þ splenocytes was similar between IL-7Ra À/À naive and WT mice. 22 In our study the percentage of CD4 þ splenocytes expressing Foxp3 were significantly increased in the IL-7Ra À/À mice compared with the WT mice (Figure 8 ). Thus despite a reduction in total numbers of T cells in IL-7Ra À/À mice, the ratio of Teff cells to Treg cells is lower in the IL-7Ra À/À mice ( Therefore, we have analyzed both
Although the regulatory properties of these cells remain to be 
Materials and methods
Animals
The C57BL/6 mice and IL-7Ra À/À mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and maintained in the animal care facility at Methodist Research Institute. Around 4-to-6-week-old male and female mice were used in the experiments. 
Induction and evaluation of EAE
To induce EAE, 4-to-6-week-old C57BL/6 (WT) and IL-7Ra À/À male and female mice were immunized with 100 mg MOGp35-55 peptide Ag in 150 ml emulsion of CFA (Sigma Chemicals) in the lower dorsum on days 0 and 7.
The mice also received (intraperitonial) 100 ng of pertussis toxin (Sigma Chemicals) on days 0 and 2. The clinical symptoms were scored every day from day 0 to 30 as follows: 0, normal; 0.5, stiff tail; 1, limp tail; 1.5, limp tail with inability to right; 2, paralysis of one limb; 2.5 paralysis of one limb and weakness of one other limb; 3, complete paralysis of both hind limbs; 4 moribund; 5, death. MCS was calculated by adding the clinical scores for one group and dividing by the total number of mice in that group.
Histological analysis
The IL-7Ra À/À and WT mice induced to develop EAE were sacrificed on day 30 by CO 2 asphyxiation and perfused by intracardiac injection of 4% paraformaldehyde and 1% glutaraldehyde in phosphate-buffered saline (PBS). Spinal cords were dissected and fixed in 10% formalin in PBS. Decalcified spinal cords were subjected to transverse sectioning of cervical, upper thoracic, lower thoracic and lumbar regions and 10 mm sections were stained with Luxol Fast Blue and hematoxylin and eosin at the Indiana University Pathology Department. Inflammation and demyelination in the spinal cord sections were assessed under a microscope in a blinded manner. The spinal cord sections were viewed as anterior, posterior and two lateral columns (four quadrants). Each quadrant displaying the infiltration of mononuclear cells or loss of myelin was assigned a score of one inflammation or one demyelination, respectively. Thus, each animal has a potential maximum score of 16 and this study represents the analyses of spinal cords from at least five mice per group. The pathological score from each group is expressed as percent positive over total number of quadrants examined. 54 Images were acquired using a fluorescence microscope with a Â 10 aperture and Â 10 objective lens (Leica, Bannockburn, IL, USA) and a digital camera (SPOT RT, SPOT Advanced software, Diagnostic Instruments, Inc., Sterling Heights, MI, USA).
T-cell proliferation assay Spleens cells were isolated from IL-7Ra
À/À and WT mice on day 14 following immunization with MOGp35-55 and cultured in 96-well tissue culture plates in RPMI medium (2 Â 10 5 200 ml À1 per well) with 0, 2.5, 5 and 10 mg ml
À1
MOGp35-55 peptide for 72 h. WST-1 reagent (10 ml per well) was added and optical density at 450 nm measured after 4 h using a titer-plate reader (Alpha Diagnostics, San Antonio, TX, USA). Spleens cells were also isolated from WT and IL-7Ra À/À mice before (naive), and after (day 14) immunization with CFA alone or in CFA þ MOGp35-55. The cells (5 Â 10 6 ml
) were incubated in PBS with 0.2 mM carboxy-fluorescein succinimidyl ester (Invitrogen, Carlsbad, CA, USA) for 5 min at 37 1C. Cells were washed and resuspended in complete RPMI medium (2.5 Â 10 6 ml
) and cultured with 0, 2.5, 5 or 10 mg ml À1 MOGp35-55 peptide. Alternatively, cells were cultured with 2 mg ml À1 anti-CD3 plus 1 mg ml
anti-CD28 antibodies or 0, 1 or 2.5 mg ml À1 ConA, for positive controls. After 72 h, cells were harvested, stained for CD4-PE (Phycoerythrin) and resuspended in PBS/ 0.1% bovine serum albumin containing 10 mg ml 
Quantitative RT-PCR
The quantitative real time polymerase chain reaction (qRT-PCR) was performed using the ABI Prism 7900 fast sequence detection system (Applied Biosystems) according to the manufacturer's instructions. Brain samples were isolated from WT and IL-7Ra À/À mice on day 14 following induction of EAE, flash frozen and stored at À80 1C until used. Five to six brain samples per group from two different experiments were pooled and total RNA was extracted using the RNeasy Mini kit according to the manufacturer's instructions (Qiagen). The RNA samples (500 ng 20 ml À1 reaction) were reverse transcribed into cDNA (RT-PCR) using random hexamer primers and TaqMan reverse transcription kit (Applied Biosystems). The cDNA (100 ng per sample) was subjected to qPCR analysis in quadruplicate using forward and reverse primers, TaqMan Universal Master Mix, and probe (10 ml per reaction) in fast optical 96-well plates. The data were analyzed using the ABI Prism 7900 relative quantification (DDCt) study software (Applied Biosystems). In this study we have used primer sets for 10 selected inflammatory genes with GAPDH as internal control (Applied Biosystems). The expression levels of inflammatory genes normalized to GAPDH are presented as arbitrary fold changes compared with control samples.
Cytokine enzyme-linked immunosorbant assay Spleen cells were isolated from IL-7Ra
À/À and WT mice on day 14 following induction of EAE and cultured in 12-well tissue culture plates in RPMI medium (1 Â 10 6 ml
À1
per well) with 0, 2.5, 5 and 10 mg ml -1 MOGp35-55 peptide. The culture supernatants were collected after 48 h and the presence of secreted IFNg, IL-17, IL-4 and IL-10 analyzed by enzyme-linked immunosorbant assay. Flat-bottomed 96-well Nunc plastic plates were coated with capture antibody at 4 1C overnight. Plates were washed and subsequently blocked with 3% bovine serum albumin in PBS for 1 h at room temperature. Recombinant cytokine standards and the culture supernatant samples were added and incubated at 4 1C overnight. After washing in PBS with 1% bovine serum albumin, the plates were incubated with detection antibody for 1 h at room temperature and then with Avidin-alkaline phosphatase for 30 min, followed by colorimetric assessment with 1 mg ml À1 p-nitrophenylphosphate prepared in 1 M diethanolamine. Optical density was measured at 405 nm after 4 h using a titer-plate reader (Alpha Diagnostics). Results were interpolated from a standard curve and expressed as ng ml À1 or pg ml À/À mice were isolated on day 14 following induction of EAE and restimulated with 1 mg ml À1 ionomycin and 50 nM phorbol 12-myristate 13-acetate for 1 h at 37 1C followed by BD GolgiStop containing monensin (Franklin Lakes, NJ, USA) for an additional 5 h. The cells were subjected to surface staining (30 min at 4 1C) followed by fixation and permeabilization with BD Cytofix/Cytoperm kit (BD Biosciences) according to the manufacturer's instructions. Next, cells were washed and stained (1 h at 4 1C) for the intracellular cytokines IL-17 and IFNg. T cells were gated on the basis of the forward scatter/side scatter properties. Spectral overlap was eliminated by appropriate compensation on the basis of single-stained controls, and gating parameters were determined using isotype controls. The cells were analyzed using a BD FACSCalibur or a BD LSRII flow cytometer (Becton Dickinson, San Jose, CA, USA) and analyzed with FlowJo software (Ashland, OR, USA).
Statistical analyses
To determine statistical significance, unpaired Student's t-tests, Wilcoxon-matched pairs tests or one-way analysis of variance tests were performed by Bonferronni's multiple comparison test using GraphPad Prism v5.0 (GraphPad Software, La Jolla, CA, USA). Post-hoc analyses were performed using Dunnett's correction. Bar graph values are means±s.e.m.
